Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)
3.5850
-0.5750 (-13.82%)
NASDAQ· Last Trade: Jul 15th, 2:43 PM EDT
Detailed Quote
Previous Close
4.160
Open
3.840
Bid
3.520
Ask
3.650
Day's Range
3.250 - 4.020
52 Week Range
2.710 - 55.90
Volume
813,760
Market Cap
3.84M
PE Ratio (TTM)
-0.7127
EPS (TTM)
-5.0
Dividend & Yield
N/A (N/A)
1 Month Average Volume
5,934,554
Chart
About Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company focused on advancing innovative solutions for cancer treatment through its development of novel therapeutics. The company specializes in research aimed at improving the effectiveness of existing cancer therapies, particularly by enhancing the response of cancer cells to radiation and chemotherapy. Shuttle Pharmaceuticals is dedicated to leveraging scientific advancements to create new medications that enhance patient outcomes and quality of life, demonstrating its commitment to addressing significant challenges in oncology. Through its proprietary technologies and drug development programs, the company strives to bring transformative therapies to market that can better support cancer patients and their healthcare providers. Read More
Kartoon Studios, Inc. (NYSE: TOON) is entering what many investors view as a catalyst-rich period following a series of developments that have significantly strengthened the company's financial position and expanded its premium content portfolio.
Investors searching for emerging growth opportunities are increasingly looking beyond large-cap leaders toward smaller companies delivering transformational corporate developments, breakthrough technologies, and significant clinical milestones. Recent announcements from NextCure, Inc. (NASDAQ: NXTC), Kartoon Studios, Inc. (NYSE American: TOON), Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH), Envoy Medical, Inc. (NASDAQ: COCH), and Peraso Inc. (NASDAQ: PRSO) highlight several companies attracting renewed investor attention as catalysts continue to build across biotechnology, artificial intelligence, healthcare technology, digital media, and advanced communications.
Gainers NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) shares
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) stock moved
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-market session. The company's market cap stands at $1.7 million. Medicus Pharma (NASDAQ:MDCX) stock rose 7.46% to
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 66.9% to $6.31 during Thursday's after-market session. The company's market cap stands at $2.1 million. INVO Fertility (NASDAQ:IVF) stock
Gaithersburg, Maryland--(Newsfile Corp. - May 14, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced...
Gaithersburg, Maryland--(Newsfile Corp. - April 30, 2026) - Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) ("Shuttle") has entered into a definitive...
